首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1550539

疫苗市场：按类型、技术、适应症、给药途径及地区分类

Vaccines Market, By Type, By Technology, By Disease Indication, By Route of Administration, By Geography

出版日期: 2024年08月16日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球疫苗市场规模为771.2亿美元，预计2031年将达1,161亿美元，2024年至2031年复合年增长率为6%。

报告范围		报告详情
基准年	2023年	2024年市场规模	771.2亿美元
实际资料	2019年至2023年	预测期	从2024年到2031年
预测 2024-2031 年复合年增长率：	6.00%	2031年价值预测	1161亿美元

图：2024 年按地区分類的疫苗市场占有率(%)

近年来，由于各种感染疾病的蔓延和疫苗製造技术的进步，全球疫苗市场经历了稳定成长。疫苗有助于增强对某些疾病的免疫力，使高风险族群免受危险感染疾病的危及生命的影响。免疫意识的提高，特别是在开发中国家，正在推动全球对先进且负担得起的疫苗的需求。此外，主要製造商推出组合疫苗有助于提高疫苗接种率并减轻医疗资源的压力。政府和国际组织对免疫计划的持续支持预计将在预测期内推动全球疫苗市场的成长。

市场动态：

全球疫苗市场主要由感染疾病率上升、疫苗製造技术进步以及政府对免疫计划的日益关注所推动。据世界卫生组织 (WHO) 称，疫苗接种每年可预防 2 至 300 万人死亡。针对某些疾病的强制性疫苗接种以及全球消除疾病的努力也推动了市场的成长。然而，新疫苗研发伴随的研发成本飙升、监管部门的严格核准以及因错误讯息而犹豫不决等因素，是阻碍疫苗广泛使用的因素。同时，无需冷藏即可承受高温的热稳定疫苗、可针对突变病毒提供保护的细胞疫苗技术以及提高低收入和中等收入国家疫苗接种率的倡议的开发将在未来继续增长。丰厚的机会。

本研究的主要特点

本报告对全球疫苗市场进行了详细分析，并呈现了以2022年为基准年的预测期（2024-2031）的市场规模和年均增长率。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

该报告根据公司亮点、产品系列、主要业绩、财务表现和策略等参数，提供了全球疫苗市场主要企业的概况。

本研究涵盖的主要企业包括辉瑞、默克、赛诺菲巴斯德、葛兰素史克 (GSK)、阿斯特捷利康、强生、CSL Limited 和印度血清研究所。

本报告中的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球疫苗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。

透过分析全球疫苗市场时所使用的各种策略矩阵，将有助于相关人员做出决策。

GlaxoSmithKline plc（GSK）
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Moderna, Inc.
AstraZeneca
Johnson & Johnson
Novavax, Inc.
CSL Limited
Emergent BioSolutions Inc.
Bharat Biotech
Serum Institute of India
BioNTech SE
Takeda Pharmaceutical Company
Sinovac Biotech Ltd.
Sinopharm（China National Pharmaceutical Group）
Vaxart, Inc.
Inovio Pharmaceuticals, Inc.
Valneva SE
Vaccitech plc

第十一章分析师建议

命运之轮
分析师观点
一致的机会图

第十二章参考文献与调查方法

参考
调查方法
关于出版商

简介目录

Product Code: CMI4914

The Global Vaccines Market is estimated to be valued at USD 77.12 Billion in 2024 and is expected to reach USD 116.10 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 77.12 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	6.00%	2031 Value Projection:	US$ 116.10 Bn

Figure. Vaccines Market Share (%), By Region 2024

The global vaccines market has been witnessing steady growth over the past few years due to the rising prevalence of various infectious diseases and technological advancements in vaccine production. Vaccines aid in building immunity against specific diseases and allow populations at risk to be protected from the life-threatening effects of dangerous infections. Growing awareness about immunization, especially in developing nations is propelling the demand for advanced and affordable vaccines globally. Furthermore, the introduction of combination vaccines by major manufacturers is encouraging higher vaccination rates and reducing the burden on healthcare resources. Continued support from governments and international organizations towards immunization programs is expected to drive the global vaccines market growth during the forecast period.

Market Dynamics:

The global vaccines market is primarily driven by the rising incidence of infectious diseases, technological advancements in vaccine production, and growing focus on immunization programs by governments. According to the World Health Organization (WHO), immunization averts an estimated 2-3 million deaths annually. Mandates on vaccination of certain diseases and worldwide efforts towards disease eradication also provide momentum to market growth. However, high R&D costs associated with new vaccine development, stringent regulatory approvals, and vaccine hesitancy due to misinformation are some of the factors hindering the widespread adoption of vaccines. On the other hand, development of thermostable vaccines that can withstand high temperatures without refrigeration, cell-based vaccine technologies offering protection against mutating viruses, and initiatives to drive vaccine uptake in low and middle-income countries are expected to unlock lucrative opportunities for players in the coming years.

Key features of the study:

This report provides in-depth analysis of the global vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Merck, Sanofi Pasteur, GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, CSL Limited, and Serum Institute of India

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaccines market.

Detailed Segmentation-

By Type Insights (Revenue, USD Bn, 2019 - 2031)
- Monovalent Vaccines
- Mulitvalent Vaccines
By Technology Insights (Revenue, USD Bn, 2019 - 2031)
- Conjugate Vaccines
- Recombinant Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Other Vaccine Technologies
By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Tablets/Capsules
- Liquids
- Creams
- Gels
- Others
By Disease Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Pneumococcal Disease
- Influenza
- Combination Vaccines
- HPV
- Meningococcal Disease
- Herpes Zoster
- Rotavirus
- MMR
- Varicella
- Hepatitis
- DTP
- Polio
- RSV
- Other Disease Indications
By Route Of Administration: Insights (Revenue, USD Bn, 2019 - 2031)
- Intramuscular
- Subcutaneous
- Oral
- Intranasal
By Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline plc (GSK)
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Moderna, Inc.
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- CSL Limited
- Emergent BioSolutions Inc.
- Bharat Biotech
- Serum Institute of India
- BioNTech SE
- Takeda Pharmaceutical Company
- Sinovac Biotech Ltd.
- Sinopharm (China National Pharmaceutical Group)
- Vaxart, Inc.
- Inovio Pharmaceuticals, Inc.
- Valneva SE
- Vaccitech plc

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Vaccines Market, By Type
- Global Vaccines Market, By Technology
- Global Vaccines Market, By Dosage Form
- Global Vaccines Market, By Disease Indication
- Global Vaccines Market, By Route of Administration
- Global Vaccines Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Vaccines Market, By Type, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Monovalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Multivalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Vaccines Market, By Technology, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inactivated and Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Vaccine Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Vaccines Market, By Dosage Form, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Tablets/Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liquids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Vaccines Market, By Disease Indication, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pneumococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Combination Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
HPV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Meningococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Herpes Zoster
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Rotavirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
MMR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Varicella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
DTP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Polio
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
RSV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Disease Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Vaccines Market, By Route of Administration, 2024-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Vaccines Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
South Africa
North Africa
Central Africa

10. COMPETITIVE LANDSCAPE

GlaxoSmithKline plc (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Moderna, Inc.
AstraZeneca
Johnson & Johnson
Novavax, Inc.
CSL Limited
Emergent BioSolutions Inc.
Bharat Biotech
Serum Institute of India
BioNTech SE
Takeda Pharmaceutical Company
Sinovac Biotech Ltd.
Sinopharm (China National Pharmaceutical Group)
Vaxart, Inc.
Inovio Pharmaceuticals, Inc.
Valneva SE
Vaccitech plc

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

疫苗市场：按类型、技术、适应症、给药途径及地区分类